Mesenchymal stem cell conditioned media (CM)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mesenchymal stem cell conditioned media (CM), covering 2026-02-25 to 2026-02-25. Get the full timeline:
Most recent: Clinical Trial Update: Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/II [Phase 2, Phase 3]